ZenenCell Obtains 'MFDS Individual Recognition' for Liver Health Improvement Ingredient

Genencell announced on the 25th that its self-developed natural material 'CA-HE50 (Centella Asiatica Extract Powder)' has obtained the 'Individual Recognition Type Health Functional Food Functional Ingredient Approval' from the Ministry of Food and Drug Safety for liver health improvement.

'CA-HE50' previously received individual recognition as a functional ingredient for eye health improvement with the same specifications from the Ministry of Food and Drug Safety in 2021. The newly recognized functionality is that it "may help liver health by protecting against non-alcoholic liver damage."

In preclinical trials of 'CA-HE50,' Genencell confirmed the suppression of chronic liver inflammation caused by oxidative stress and an increase in antioxidant activity. Through human application trials, it was proven to be effective for liver health by improving liver function-related enzymes, triglycerides, and cholesterol. Comparing key liver markers before and after intake of 'CA-HE50' in human trials showed reductions of 27.2%, 36.7%, and 18.8% in AST, ALT, and GGT, respectively.

A Genencell representative stated, "We have secured market competitiveness with a dual-functional ingredient that has high demand for eyes and liver," adding, "We aim to enter the health functional food ingredient market within this year."

For the commercialization of 'CA-HE50,' Genencell has completed raw material procurement and prototype production and signed domestic and international distribution rights contracts with a specialized health functional food distribution company. They will also participate in overseas exhibitions starting next month.

CA-HE50 has completed domestic and European patent registrations as well as international trademark registration. Patents have been filed in the United States, Japan, China, and other countries.

Individual recognition type functional ingredients refer to materials that are not listed or registered in official notifications but are independently researched by companies to prove their health benefits through experiments and recognized by the Ministry of Food and Drug Safety. Although the recognition criteria are stringent, including functionality, safety, manufacturing methods, standards, and intake verification, once approved, companies can hold exclusive manufacturing and sales rights for a certain period.